31.43% to Target, Liberum Capital Keeps “Buy” Rating for Balfour Beatty PLC (LON:BBY) Stock; University Of Notre Dame Du Lac Lowered Its Cvs Health (CVS) Holding

December 7, 2017 - By Dolores Ford

University Of Notre Dame Du Lac decreased Cvs Health Corp (CVS) stake by 31.03% reported in 2017Q2 SEC filing. University Of Notre Dame Du Lac sold 23,823 shares as Cvs Health Corp (CVS)’s stock declined 4.23%. The University Of Notre Dame Du Lac holds 52,954 shares with $4.26 million value, down from 76,777 last quarter. Cvs Health Corp now has $72.31 billion valuation. The stock increased 0.52% or $0.37 during the last trading session, reaching $71.38. About 12.37M shares traded or 42.44% up from the average. CVS Health Corporation (NYSE:CVS) has declined 24.40% since December 7, 2016 and is downtrending. It has underperformed by 41.10% the S&P500.

They currently have a GBX 350.00 target price per share on Balfour Beatty PLC (LON:BBY). Liberum Capital’s target would suggest a potential upside of 31.43% from the company’s previous close. This was revealed to clients and investors in a report on 7 December.

Since June 9, 2017, it had 0 insider purchases, and 2 sales for $2.31 million activity. On Friday, June 9 the insider Watson Mathew sold $29,679. Another trade for 22,255 shares valued at $1.24 million was sold by Saksena Asheesh.

The stock increased 1.02% or GBX 2.7 during the last trading session, reaching GBX 266.6. About 676,184 shares traded. Balfour Beatty plc (LON:BBY) has 0.00% since December 7, 2016 and is . It has underperformed by 16.70% the S&P500.

Investors sentiment decreased to 0.79 in 2017 Q2. Its down 0.22, from 1.01 in 2017Q1. It dropped, as 43 investors sold Balfour Beatty plc shares while 213 reduced holdings. 88 funds opened positions while 113 raised stakes. 253.45 million shares or 5.82% less from 269.11 million shares in 2017Q1 were reported. 26,713 were accumulated by Convergence Ltd. Scopus Asset Mgmt Ltd Partnership invested in 600,000 shares or 0.37% of the stock. Millennium Ltd Liability Corporation invested 0.09% in Balfour Beatty plc (LON:BBY). Euclidean Techs Management Ltd Company has 34,361 shares. Parsons Cap Mngmt Ri holds 0.03% in Balfour Beatty plc (LON:BBY) or 4,048 shares. American Interest Gru Inc has invested 2.22% in Balfour Beatty plc (LON:BBY). Gyroscope Cap Management Ltd Liability Company invested 2.82% in Balfour Beatty plc (LON:BBY). Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Mngmt has invested 0.16% in Balfour Beatty plc (LON:BBY). Caisse De Depot Et Placement Du Quebec reported 0% stake. Pillar Pacific Capital Mngmt Limited Liability accumulated 7,280 shares. Massachusetts Financial Services Ma invested in 0.09% or 3.64M shares. Lombard Odier Asset Management (Switzerland) invested in 21,027 shares. Comerica Natl Bank owns 66,643 shares or 0.03% of their US portfolio. 635 were accumulated by Fin Architects Inc. Gateway Invest Advisers Lc has 54,947 shares.

Among 11 analysts covering Balfour Beatty PLC (LON:BBY), 6 have Buy rating, 1 Sell and 4 Hold. Therefore 55% are positive. Balfour Beatty PLC has GBX 350 highest and GBX 240 lowest target. GBX 318.78’s average target is 19.57% above currents GBX 266.6 stock price. Balfour Beatty PLC had 75 analyst reports since August 10, 2015 according to SRatingsIntel. The stock of Balfour Beatty plc (LON:BBY) earned “Buy” rating by Liberum Capital on Wednesday, May 4. Bank of America upgraded the shares of BBY in report on Tuesday, April 11 to “Buy” rating. The rating was maintained by Liberum Capital on Wednesday, August 12 with “Buy”. Liberum Capital maintained Balfour Beatty plc (LON:BBY) rating on Friday, June 17. Liberum Capital has “Buy” rating and GBX 320 target. The stock of Balfour Beatty plc (LON:BBY) earned “Buy” rating by Liberum Capital on Monday, June 26. The rating was upgraded by RBC Capital Markets on Monday, August 10 to “Outperform”. JP Morgan maintained the stock with “Neutral” rating in Friday, March 17 report. The firm has “Buy” rating by Numis Securities given on Wednesday, August 17. Peel Hunt maintained Balfour Beatty plc (LON:BBY) on Wednesday, August 16 with “Add” rating. The stock of Balfour Beatty plc (LON:BBY) earned “Buy” rating by Berenberg on Thursday, February 9.

Balfour Beatty plc finances, develops, builds, and maintains infrastructure in the United Kingdom, the United States, and internationally. The company has market cap of 1.81 billion GBP. It operates through Construction Services, Support Services, and Infrastructure Investments divisions. It has a 33.75 P/E ratio. The Construction Services segment offers building, civil and ground engineering, mechanical and electrical services, rail engineering, and refurbishment and fit-out services.

Analysts await CVS Health Corporation (NYSE:CVS) to report earnings on February, 8. They expect $1.90 earnings per share, up 11.11% or $0.19 from last year’s $1.71 per share. CVS’s profit will be $1.92B for 9.39 P/E if the $1.90 EPS becomes a reality. After $1.50 actual earnings per share reported by CVS Health Corporation for the previous quarter, Wall Street now forecasts 26.67% EPS growth.

Since June 12, 2017, it had 0 insider buys, and 1 sale for $18.44 million activity. Denton David M also sold $18.44 million worth of CVS Health Corporation (NYSE:CVS) shares.

Investors sentiment decreased to 0.92 in Q2 2017. Its down 0.17, from 1.09 in 2017Q1. It dived, as 84 investors sold CVS shares while 559 reduced holdings. 108 funds opened positions while 483 raised stakes. 803.96 million shares or 0.96% less from 811.73 million shares in 2017Q1 were reported. Chase Investment Counsel Corp invested 0.14% in CVS Health Corporation (NYSE:CVS). Buckhead Mgmt Llc stated it has 110,684 shares or 1.62% of all its holdings. Mechanics Bancorporation Trust Department holds 1.03% of its portfolio in CVS Health Corporation (NYSE:CVS) for 53,809 shares. Geneva Advsr Ltd holds 43,014 shares. Regentatlantic Cap Ltd Liability Com holds 151,989 shares. 4,265 were reported by Rodgers Brothers. Lsv Asset Mgmt holds 0.7% or 4.88M shares in its portfolio. Crawford Invest Counsel reported 687,232 shares. Bnp Paribas Asset Mgmt Sa accumulated 557,178 shares. Columbia L L C Mngmt holds 0.21% of its portfolio in CVS Health Corporation (NYSE:CVS) for 20,607 shares. Hightower Advsrs Ltd Com accumulated 257,096 shares or 0.18% of the stock. Sumitomo Mitsui Asset Mgmt Company Limited has 0.11% invested in CVS Health Corporation (NYSE:CVS). Busey Tru Company reported 2,901 shares. Exxonmobil Mgmt Tx invested 0.39% in CVS Health Corporation (NYSE:CVS). Toth Financial Advisory Corp reported 1.88% of its portfolio in CVS Health Corporation (NYSE:CVS).

Among 25 analysts covering CVS Health (NYSE:CVS), 17 have Buy rating, 0 Sell and 8 Hold. Therefore 68% are positive. CVS Health had 58 analyst reports since July 22, 2015 according to SRatingsIntel. Citigroup maintained CVS Health Corporation (NYSE:CVS) on Friday, November 3 with “Neutral” rating. The stock has “Buy” rating by Argus Research on Monday, August 10. Robert W. Baird initiated it with “Outperform” rating and $108 target in Friday, January 22 report. The company was downgraded on Monday, August 14 by Wolfe Research. On Thursday, August 20 the stock rating was maintained by Deutsche Bank with “Hold”. The stock has “Buy” rating by Vetr on Monday, August 24. The rating was maintained by Mizuho on Thursday, June 23 with “Buy”. Deutsche Bank maintained CVS Health Corporation (NYSE:CVS) rating on Wednesday, July 22. Deutsche Bank has “Hold” rating and $117 target. On Wednesday, August 19 the stock rating was reinitiated by Evercore with “Buy”. The firm has “Neutral” rating by Goldman Sachs given on Thursday, December 17.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.